Chalcogenopyrylium Dyes
J ournal of Medicinal Chemistry, 1999, Vol. 42, No. 19 3963
Photodynamic Effect of meso-Tetra(hydroxyphenyl)porphine and
its Corresponding Chlorin in Normal and Tumor Tissues of Mice
Bearing Mammary Carcinoma. Cancer Res. 1995, 55, 2620-
2626. (c) Henderson, B. W.; Dougherty, T. J . How Does Photo-
dynamic Therapy Work? Photochem. Photobiol. 1992, 55, 145-
157.
(11) Rideout, D. G.; Calogeropooulou, T.; J aworski, J . S.; Dagnino,
R., J r.; McCarthy, M. R. Phosphonium Salts Exhibiting Selective
Anticarcinoma Activity in Vitro. Anticancer Drug Des. 1989, 4,
465-480.
(12) Kawakami, M.; Koya, K.; Ukai, T.; Tatsuta, N.; Ikegawa, A.;
Ogawa, K.; Shishido, T.; Chen, L. B. Synthesis and Evaluation
of Novel Rhodacyanine Dyes That Exhibit Antitumor Activity.
J . Med. Chem. 1997, 40, 3151-3160.
(2) (a) Modica-Napolitano, J . S.; J oyal, J . L.; Ara, G.; Oseroff, A. R.;
Aprille, J . R. Mitochondrial Toxicity of Cationic Photosensitizers
for Photochemotherapy. Cancer Res. 1990, 50, 7876-7881. (b)
Morgan, J .; Whitaker, J . E.; Oseroff, A. R. GRP78 Induction by
Calcium Ionophore Potentiates Photodynamic Therapy Using the
Mitochondrial Targeting Dye Victoria Blue BO. Photochem.
Photobiol. 1998, 67, 155-164.
(3) Noodt, B. B.; Rodal, G. H.; Wainwright, M.; Peng, Q.; Horobin,
R.; Nesland, J . M.; Berg, K. Apoptosis Induction by Different
Pathways with Methylene Blue Derivative and Light from
Mitochondrial Sites in V79 Cells. Int. J . Cancer 1998, 75, 941-
948.
(13) (a) Modica-Napolitano, J . S.; Koya, K.; Weisberg, E.; Brunelli,
B. T.; Li, Y.; Chen, L. B. Selective Damage to Carcinoma
Mitochondria by the Rhodacyanine MKT-077. Cancer Res. 1996,
56, 544-550. (b) Koya, K.; Li, Y.; Wang, H.; Ukai, T.; Tatsuta,
N.; Kawakami, M.; Shishido, T.; Chen, L. B. MKT-077, a Novel
Rhodacyanine Dye in Clinical Trials, Exhibits Anticarcinoma
Activity in Preclinical Studies Based on Selective Mitochondrial
Accumulation. Cancer Res. 1996, 56, 538-543.
(14) Sun, X.; Wong, J . R.; Song, K.; Hu, J .; Garlid, K. D.; Chen, L. B.
AA1,
A Newly Synthesized Monovalent Lipophilic Cation,
(4) (a) Cincotta, L.; Foley, J . W.; Cincotta, A. H. Phototoxicity, Redox
Behavior, and Pharmacokinetics of Benzophenoxazine Analogues
in EMT-6 Murine Sarcoma Cells. Cancer Res. 1993, 53, 2571-
2580. (b) Lin, C. W.; Shulok, J . R.; Kirley, S. D.; Bachelder, C.
M.; Flotte, T. J .; Sherwood, M. E.; Cincotta, L.; Foley, J . W.
Photodynamic Destruction of Lysosomes Mediated by Nile Blue
Photosensitizers. Photochem. Photobiol. 1993, 58, 81-91. (c) Lin,
C. W.; Shulok, J . R.; Kirley, S. D.; Cincotta, L.; Foley, J . W.
Lysosomal Localization and Mechanism of Uptake of Nile Blue
Photosensitizers in Tumor Cells. Cancer Res. 1991, 51, 2710-
2719. (d) Cincotta, L.; Foley, J . W.; MacEachern, T.; Lampros,
E.; Cincotta, A. H. Novel Photodynamic Effects of a Benzophe-
nothiazine on Two Different Murine Sarcomas. Cancer Res.
1994, 54, 1249-1258.
(5) (a) Oseroff, A. R.; Ohuoha, D.; Ara, G.; McAuliffe, D.; Foley, J .;
Cincotta, L. Intramitochondrial Dyes Allow Selective in vitro
Photolysis of Carcinoma. Proc. Natl. Acad. Sci. U.S.A. 1986, 83,
9729-9733. (b) Ara, G.; Aprille, J . R.; Malis, C. D.; Kane, S. B.;
Cincotta, L.; Foley, J .; Bonventre, J . V.; Oseroff, A. R. Mecha-
nisms of Mitochondrial Photosensitization by the Cationic Dye,
N,N′-Bis(2-ethyl-1,3-dioxylene)kryptocyanine (EDKC): Prefer-
ential Inactivation of Complex I in the Electron Transport Chain.
Cancer Res. 1987, 47, 6580-6585. (c) Lee, C.; Wu, S. S.; Chen,
L. B. Photosensitization by 3,3′-Dicyclohexyloxacarbocyanine
Iodide: Specific Disruption of Microtubules and Inactivation of
Organelle Motility. Cancer Res. 1995, 55, 2063-2069.
(6) (a) Modica-Napolitano, J . S.; Brunelli, B. T.; Koya, K.; Chen, L.
B. Photoactivation Enhances the Mitochondrial Toxicity of the
Cationic Rhodacyanine MKT-077. Cancer Res. 1998, 58, 71-
75. (b) Modica-Nopolitano, J . S.; Koya, K.; Weisberg, E.; Brunelli,
B. T.; Li, Y.; Chen, L. B. Selective Damage to Carcinoma
Mitochondria by the Rhodacyanine MKT-077. Cancer Res. 1996,
56, 544-550.
(7) (a) Detty, M. R.; Merkel, P. B.; Hilf, R.; Gibson, S. L.; Powers,
S. K. Chalcogenapyrylium Dyes as Photochemotherapeutic
Agents. 2. Tumor Uptake, Mitochondrial Targeting, and Singlet-
Oxygen-Induced Inhibition of Cytochrome c Oxidase. J . Med.
Chem. 1990, 33, 1108-1116. (b) Kessel, D. Intracellular Local-
ization of a Chalcogenapyrylium Dye Probed by Spectroscopy
and Sites of Photodamage. Photochem. Photobiol. 1991, 53, 73-
78. (c) Powers, S. K.; Walstad, D. L.; Brown, J . T.; Detty, M. R.;
Watkins, P. J . Photosensitization of Human Glioma Cells by
Chalcogenapyrylium Dye. J . Neuro-Oncol. 1989, 7, 179-187.
(8) (a) Davis, S.; Weiss, M. J .; Wong, J . R.; Lampidis, T. J .; Chen,
L. B. Mitochondrial and Plasma Membrane Potentials Cause
Unusual Accumulation and Retention of Rhodamine 123 by
Breast Adenocarcinoma-Derived MCF-7 Cells. J . Biol. Chem.
1985, 260, 13844-13850. (b) Lampidis, T. J .; Bernal, S. D.;
Summerhayes, I. C.; Chen, L. B. Selective Toxicity of Rhodamine-
123 in Carcinoma Cells in Vitro. Cancer Res. 1983, 43, 716-
720. (c) Bernal, S. D.; Lampidis, T. J .; McIsaac, R. M.; Chen, L.
B. Anticarcinoma Activity in vivo of Rhodamine 123, a Mito-
chondrial-Specific Dye. Science 1986, 222, 169-172. (d) Modica-
Napolitano, J . S.; Aprille, J . R. Basis for the Selective Cytotox-
icity of Rh123. Cancer Res. 1987, 47, 4361-4365.
Expresses Potent in vivo Antitumor Activity. Cancer Res. 1994,
54, 1465-1471.
(15) (a) Nadakavukaren, K. K.; Nadakavukaren, J . J .; Chen, L. B.
Increased Rhodamine 123 Uptake by Carcinoma Cells. Cancer
Res. 1986, 45, 6093-6099. (b) Wong, J . R.; Chen, L. B. Recent
Advances in the Study of Mitochondria in Living Cells. Adv. Cell
Biol. 1988, 2, 263-290.
(16) Leonard, K. A.; Nelen, M. I.; Anderson, L. T.; Gibson, S. L.; Hilf,
R.; Detty, M. R. 2,4,6-Triarylchalcogenopyrylium Dyes Related
in Structure to the Antitumor Agent AA1 as in Vitro Sensitizers
for the Photodynamic Therapy of Cancer. J . Med. Chem. 1999,
42, 3942-3952.
(17) (a) Detty, M. R.; Luss, H. R. Addition of Disodium Chalcogenides
to 1,5-Bis(trimethylsilyl)penta-1,4-diyn-3-one. Syntheses, Struc-
ture, and Reactivity of the Parent ∆-4H-Chalcogenapyran-4-
ones. Organometallics 1992, 11, 2157-2162. (b) Detty, M. R.;
Hassett, J . W.; Murray, B. J .; Reynolds, G. A. ∆.4,4′-4-Chalco-
genapyranyl-4H-chalcogenapyrans. Synthesis, Electrochemical
Oxidation, and ESR Investigations of Radical-Cation States.
Tetrahedron 1985, 45, 4853-4858.
(18) Detty, M. R.; Murray, B. J . Telluropyrylium Dyes. 1. 2,6-
Diphenyltelluropyrylium Dyes. J . Org. Chem. 1982, 47, 5235-
5242.
(19) Detty, M. R.; Geer, S. M.; Wadsworth, D. H. The Preparation of
Arylpropiolate Esters from Trichlorocyclopropenium Cation and
the Elaboration of the Esters to Unsymmetrical 1,4-Pentadiyn-
3-ones and Unsymmetrical Tellurapyranones. J . Org. Chem.
1987, 52, 3662-3267.
(20) Wong M. S.; Nicoud, J .-F. Synthesis and Computational Studies
of Hyperpolarizable Zig-Zag Chromophores. Tetrahedron Lett.
1994, 35, 6113-6116.
(21) Detty, M. R.; McKelvey, J . M.; Luss, H. R. Tellurapyrylium Dyes.
2. The Electron-Donating Properties of the Chalcogen Atoms to
the Chalcogenapyrylium Nuclei and Their Radical Dications,
Neutral Radicals, and Anions. Organometallics 1988, 7, 1131-
1141.
(22) Powers, S. K.; Detty, M. R. Photodynamic Therapy with Chal-
cogenapyrylium Dyes. In Photodynamic Therapy of Neoplastic
Disease; Kessel, D., Ed.; CRC Press: Boca Raton, FL, 1990; pp
308-328.
(23) (a) Wan, S.; Parrish, J . A.; Anderson, R. R.; Madden, M.
Transmittance of Nonionizing Radiation in Human Tissue.
Photochem. Photobiol. 1981, 34, 679-684. (b) Svaasand, L. O.;
Ellingsen, R. Optical Penetration in Human Intracranial
Tumors. Photochem. Photobiol. 1985, 41, 73-76.
(24) Merkel, P. B.; Detty, M. R. Unpublished results.
(25) Aveline, B. M.; Redmond, R. W. Can Cellular Phototoxicity Be
Accurately Predicted on the Basis of Sensitizer Photophysics?
Photochem. Photobiol. 1999, 69, 306-316.
(26) Fishbein, L. In Metals and Their Compounds in the Environment;
Merian, E., Ed.; VCH Publishers: New York, 1991; Chapter
II.28, pp 1211-1226.
(27) Longnecker, M. P.; Taylor, P. R.; Levander, O. A.; Howe, M.;
Veillon, C.; McAdam, P. A.; Patterson, K. Y.; Holden, J . M.;
Stampfer, M. J .; Morris, J . S. Selenium in Diet, Blood, and
Toenails in Relation to Human Health in a Seleniferous Area.
Am. J . Clin. Nutr. 1991, 53, 1288-1294.
(28) (a) Nyska, A.; Waner, T.; Pirak, M.; Albeck, M.; Sredni, B.
Toxicity Study in Rats of a Tellurium Based Immunomodulating
Drug, AS-101: A Potential Drug for AIDS and Cancer Patients.
Arch. Toxicol. 1989, 63, 386-393. (b) Sredni, B.; Caspi, R. R.;
Klein, A.; Kalechman, Y.; Danziger, Y.; BenYa’akov, M.; Tamari,
T.; Shalit, F.; Albeck, M. A New Immunomodulating Compound
(AS-101) with Potential Therapeutic Application. Nature 1987,
330, 173-176. (c) Albeck, M.; Pavliv, L.; Sredni, B. New
Complexes of Tellurium and Selenium Compounds Having
Improved Solubility, for Induction of Cytokine(s). DK Patent
167148B, 1993.
(9) Weiss, M. J .; Wong, J . R.; Ha, C. S.; Bleday, R.; Salem, R. R.;
Steele, G., J r.; Chen, L. B. Dequalinium, a Topical Antimicrobial
Agent Displays Anticarcinoma Activity Based on Selective
Mitochondrial Accumulation. Proc. Natl. Acad. Sci. U.S.A. 1987,
84, 5444-5448.
(10) (a) Anderson, W. M.; Delinck, D. L.; Benniner, L.; Wood, J . M.;
Smiley, S. T. Cytotoxic Effect of Thiacarbocyanine Dyes on
Human Colon Carcinoma Cells and Inhibition of Bovine Heart
Mitochondrial NADH-Ubiquinone Reductase Activity via
a
Rotenone-type Mechanism by Two of the Dyes. Biochem. Phar-
macol. 1993, 45, 691-696. (b) Minami, I.; Kozai, Y.; Nomura,
H.; Tashiro, T. Cyanine Dyes, New Potent Antitumor Agents.
Chem. Pharm. Bull. 1982, 30, 3106-3120.